Test groups (true negatives/non‐COVID cases) Specificity (95% CI) |
||||||
IgG | IgM | IgG or IgM | Total Ab | IgA | IgA or IgG | |
Overall result | 96 (6036/6176) | 44 (2492/2625) | 36 (2047/2175) | 22 (1407/1411) | 5 (278/311) | 2 (203/219) |
98.6 (98.0, 99.0) |
97.0 (95.1, 98.2) |
96.8 (94.4, 98.2) |
99.8 (98.6, 100) |
89.1 (80.6, 94.2) |
92.7 (88.4, 95.5) |
|
By test method | ||||||
ELISA | 28 (1573/1619) | 8 (495/503) | 3 (261/270) | 3 (158/158) | 5 (278/311) | 2 (203/219) |
98.0 (96.5, 98.8) |
98.8 (96.6, 99.6) |
96.9 (85.4, 99.4) |
100a (97.7, 100)** |
89.1 (80.6, 94.2) |
92.7 (88.4, 95.5) |
|
CLIA | 34 (2465/2514) | 4 (202/204) | 1 (20/20) | 16 (1249/1253) | ||
98.9 (98.1, 99.4) |
99.4 (96.2, 99.9) |
100a (83.2, 100)** |
99.8 (98.5, 100) |
|||
Lateral flow/CGIA/FIA | 34 (1998/2043) | 32 (1795/1918) | 31 (1707/1826) | |||
98.6 (97.6, 99.2) |
95.4 (92.8, 97.0) |
96.4 (93.7, 98.0) |
||||
COMPARISON | 0.2587 | 0.0097 | 0.4655 | |||
By antigen | ||||||
N‐based | 29 (1889/1916) | 11 (540/559) | 6 (389/397) | 12 (786/787) | ||
99.1 (98.3, 99.5) |
97.5 (93.9, 99.0) |
99.0 (95.1, 99.8) |
99.7 (98.2, 99.9) |
|||
S‐based | 38 (2668/2738) | 8 (719/746) | 10 (652/671) | 10 (656/657) | 5 (278/311) | 2 (203/219) |
98.3 (97.3, 99.0) |
97.5 (93.0, 99.1) |
99.0 (96.2, 99.7) |
99.8 (98.3, 100) |
89.1 (80.6, 94.2) |
92.7 (88.4, 95.5) |
|
N‐ and S‐based | 17 (877/895) | 15 (718/755) | 10 (500/542) | |||
98.9 (97.4, 99.5) |
97.7 (94.5, 99.1) |
95.9 (88.5, 98.6) |
||||
Unclear/not reported | 12 (602/627) | 10 (515/565) | 10 (506/565) | |||
96.9 (94.0, 98.4) |
94.0 (87.2, 97.3) |
90.9 (85.6, 94.4) |
||||
0.2515 | 0.9853 | 0.1613 | 0.6053 | |||
aP value obtained using ‘meqrlogit’; P < 0.0001 (comparison excluded ‘other/mixed/unclear’ group) *95% exact binomial confidence interval **97.5% one‐sided exact binomial confidence interval CI: confidence interval CGIA: colloidal gold immunoassayCLIA: chemiluminescent immunoassayELISA: enzyme‐linked immunoassayFIA: fluorescence immunoassay |